Expert Review of Hematology

Article	Citations
CD123-targeted therapy in acute myeloid leukemia	51
What is the future of digital tools to help manage pain in sickle cell disease patients?	50
Immune thrombocytopenia and pregnancy: challenges and opportunities in diagnosis and management	42
Acalabrutinib: a bruton tyrosine kinase inhibitor for the treatment of chronic lymphocytic leukemia	42
Platelets: the point of interconnection among cancer, inflammation and cardiovascular diseases	34
Do we need more guidance on thrombophilia testing? Challenges and special considerations	31
Upfront therapy for diffuse large B-cell lymphoma: looking beyond R-CHOP	26
Frequencies of glycosylphosphatidylinositol (GPI)-deficient cells using high-sensitivity flow cytometry as per the 2018 ICCS/ESCCA consensus guideline in patients with hematologic malignancy, aplastic	24
Are we closer to a standard of care for Richter’s syndrome? Novel treatments on the horizon	24
From bench to bedside: bridging the gaps in best practices for real-world chronic myeloid leukemia care	22
Phase II single-arm study of brentuximab vedotin in Chinese patients with relapsed/refractory classical Hodgkin lymphoma or systemic anaplastic large cell lymphoma	21
Hemophagocytic lymphohistiocytosis in Egyptian children: diagnosis, treatment challenges, and outcome	20
The evolving management algorithm for the patient with newly diagnosed cold agglutinin disease	20
COVID-19 associated with immune thrombocytopenia: a systematic review and meta-analysis	20
A combination of carfilzomib, dexamethasone, and daratumumab for treatment of adult patients with relapsed/refractory multiple myeloma in two dosing regimens: once-weekly and twice-weekly	20
Hematological parameters and X-ray exposure among medical radiation workers: a systematic review and meta-analysis	20
The expression of CD30 and its clinico-pathologic significance in peripheral T-cell lymphomas	19
Are myelodysplastic syndromes ready for venetoclax? Exploring future potential and considerations	17
Managing complications secondary to Waldenström’s macroglobulinemia	17
Past, present, and future of orthopedic surgery in hemophilia: looking to a world without bleeding and arthropathy in the near future	17
Correlation between hematocrit and the risk of common human cancers: results of a 1999–2020 observational survey and Mendelian randomization analysis	16
Allogeneic hematopoietic stem cell transplantation for acute lymphoblastic leukemia: current status and future directions mainly focusing on a Chinese perspective	15
Efanesoctocog alfa for the prevention and treatment of bleeding in patients with hemophilia A	15
Relapse and resistance in acute myeloid leukemia post venetoclax: improving second lines therapy and combinations	14
Extended post-discharge thromboprophylaxis in hospitalized COVID-19 patients	13

Screening and interventional strategies for the late effects and toxicities of hematological malignancy treatments in pediatric survivors	13
Sickle cell disease and infertility risks: implications for counseling and care of affected girls and women	13
BTK inhibitors: moving the needle on the treatment of chronic lymphocytic leukemia	13
Etranacogene dezaparvovec for the treatment of adult patients with severe and moderately severe hemophilia B	12
Late effects of hemopoietic stem cell transplant for sickle cell disease: monitoring and management	12
The future of siRNA-mediated approaches to treat von Willebrand disease	12
Evaluating ropeginterferon alfa-2b for the treatment of adults with polycythemia vera	12
Voxelotor for the treatment of sickle cell disease in pediatric patients	11
Emerging concepts for assessing and predicting treatment-free remission in chronic myeloid leukemia patients	11
Cost-effectiveness analysis of azacitidine maintenance therapy in patients with acute myeloid leukemia	11
New directions to develop therapies for people with hemophilia	11
Efficacy and safety of phosphatidylinositol 3-kinase inhibitors in patients with chronic lymphocytic leukemia: a meta-analysis and systematic review	11
Patient-centered care in von Willebrand disease: are we there yet?	11
Managing blood supplies during natural disasters, humanitarian emergencies, and pandemics: lessons learned from COVID-19	11
Bone marrow aspirate or biopsy for multiple myeloma: when percentages matter!	11
Thrombotic events in children and adolescent patients with SARS-CoV-2 infection: a systematic review with meta-analysis on incidence and management	10
An expert spotlight on inferior vena cava filters	10
Radiation therapy prior to CAR T-cell therapy in lymphoma: impact on patient outcomes	10
BCL-2 inhibition in acute myeloid leukemia: resistance and combinations	10
The National Hemophilia Foundation’s State of the Science Research Summit: the foundation of a national research blueprint for inherited bleeding disorders	10
Molecular targets for the treatment of AML in the forthcoming 5th World Health Organization Classification of Haematolymphoid Tumours	10
A toolmaker’s perspective on CRISPR-directed gene editing as a therapeutic strategy for leukemia and beyond	10
Impact of atrial fibrillation in onco-hematological patients in Europe: a targeted literature review	10
Development and internal validation of a prediction model for patients with hematologic diseases of fall risk: a cohort study	10
Is next-generation sequencing the future of measurable residual disease assays for Philadelphia chromosome-positive acute lymphoblastic leukemia?	9
Emicizumab and unmet needs of patients with hemophilia a who are managed with replacement therapies	9
Dose optimisation of ponatinib in chronic phase chronic myeloid leukemia	8
Optimizing long-term joint health in the treatment of hemophilia	8
Rivaroxaban plus aspirin after lower–extremity revascularization	8
Hematology in the post-COVID era: spotlight on vaccine-induced immune thrombotic thrombocytopenia and a conceptual framework (the 4P’s) for anti-PF4 diseases	8
Building the foundation for a community-generated national research blueprint for inherited bleeding disorders: facilitating research through infrastructure, workforce, resources and funding	8
Bad players in AL amyloidosis in the current era of treatment	8
Pegcetacoplan: the first and only C3-targeted therapy for the treatment of adults with paroxysmal nocturnal hemoglobinuria	8
Immunodeficiency-associated Hodgkin lymphoma	8
Lived experience experts: a name created by us for us	8
A real-world evidence analysis of the impact of switching from factor VIII to emicizumab prophylaxis in patients with hemophilia A without inhibitors	8
Oral decitabine in acute myeloid leukemia: assessing efficacy, safety, and future implications for older patients	7
Advances in our understanding of genetic markers and targeted therapies for pediatric LCH	7
The impact of oral health promotion on the quality of life of children with bleeding disorders: fighting misconceptions	7
Monoclonal antibodies used for the management of hemataological disorders	7
Advancements in targeting CD30 for lymphoma therapy: a historical perspective and future directions	7
Is the occurrence of deep vein thrombosis related to the fracture site? A two-sample Mendelian randomization study	7
Long-term follow-up of patients with hairy cell leukemia in the south of Iran	7
Trends of chronic lymphocytic leukemia incidence and mortality in the United States: a population-based study over the last four decades	7
Hematological disorders in children with Down syndrome	7
An update on novel therapies for treating patients with arterial thrombosis	7
What is the importance of monitoring iron levels in different organs over time with magnetic resonance imaging in transfusion-dependent thalassemia patients?	7
A review of the isocitrate dehydrogenase inhibitors in management of adult patients with AML and MDS	7
Role of volumetric analyses on [18F]FDG PET/CT in pediatric Hodgkin lymphoma	7
MRI detection of brain abnormality in sickle cell disease	7

Building the foundation for a community-generated national research blueprint for inherited bleeding disorders: research priorities for mucocutaneous bleeding disorders	7
Novel mechanisms of action of emerging therapies of hereditary thrombotic thrombocytopenic purpura	7
Circ_0035381 contributes to the progression of acute myeloid leukemia via regulating miR-186-5p/CDCA3 pathway	6
Sickle cell disease in gulf cooperation council countries: a systematic review	6
Revisiting the prognostic role of FLT3 mutations in acute myelogenous leukemia	6
Genetic variant of endothelial protein C receptor genes and its serum level in B thalassemic children	6
Curative effect of motherwort combined with ethinylestradiol-cyproterone acetate on dysfunctional uterine bleeding	6
Bone marrow morphological features and therapy in patients with Philadelphia-negative neoplasms	6
Bridging the gap: how do we enroll more racial-ethnic minority patients in hematological drug trials?	6
Improving outcomes and quality of life for patients with transfusion-dependent β-thalassemia: recommendations for best clinical practice and the use of novel treatment strategies	6
An evaluation of venetoclax in combination with azacitidine, decitabine, or low-dose cytarabine as therapy for acute myeloid leukemia	6
Problems faced by people with hemophilia aged 18–35 years in social life: a qualitative study	6
Exploring health disparities in diagnosing multiple myeloma	6
Novel BCR-ABL1 tyrosine kinase inhibitors in the treatment of chronic myeloid leukemia	6
Pomalidomide combined with dexamethasone for the treatment of relapsed/refractory multiple myeloma: a systematic review and meta-analysis	6
An evaluation of mitapivat for the treatment of hemolytic anemia in adults with pyruvate kinase deficiency	5
Challenges in the diagnosis of thrombotic thrombocytopenic purpura	5
Navigating the gap between guidelines and practical challenges in selecting first-line therapy for chronic lymphocytic leukemia	5
Understanding the interplay between chronic lymphocytic leukemia and type 2 diabetes	5
Exploring the genetic relationship between deep vein thrombosis and plasma protein: a new research idea	5
Avapritinib for Systemic Mastocytosis	5
Identifying prognostic gene panels in acute myeloid leukemia	5
Targeting von Willebrand disease: the current status and future directions of management therapies	5
New approaches to managing relapsed/refractory Hodgkin lymphoma: the role of checkpoint inhibitors and beyond	5
A systematic literature review of the epidemiology, quality of life, and economic burden, including disease pathways and treatment patterns of relapsed/refractory classical Hodgkin lymphoma	5
Secondary primary malignancies after treatment with chemo-immunotherapy in treatment-naïve patients with CLL: a systematic literature review	5
Practical tips for managing FLT3 mutated acute myeloid leukemia with midostaurin	5
Development of CD30 CAR-T cells in refractory or relapsed Hodgkin’s lymphoma	5
Challenges facing minimal residual disease testing for acute myeloid leukemia and promising strategies to overcome them	5
Revisiting the role of measurable residual disease in FLT3 mutated acute myelogenous leukemia	5
HIV-1 infection in sickle cell disease and sickle cell trait: role of iron and innate response	5
NSAIDS/COXIBS for the treatment of musculoskeletal pain secondary to hemophilic arthropathy	5
Real-world comparison of direct-acting oral anticoagulants and vitamin K antagonists in chronic kidney disease: a systematic review and meta-analysis	4
Magnitude of anemia and associated factors among adult patients at Baso Liben District: a cross-sectional study	4
Real-world treatment patterns and outcomes of triple-class treated patients with multiple myeloma in the United States	4
Characterizing the ideal patient for treatment with inotuzumab ozogamicin for relapsed/refractory acute lymphoblastic leukemia: a systematic literature review	4
Modifiable lifestyle risk factors and survival after diagnosis with multiple myeloma	4
Efficacy and safety evaluation of eptacog beta (coagulation factor VIIa [recombinant]-jncw) for the treatment of hemophilia A and B with inhibitors	4
The role of staging in multiple myeloma	4
Nutritional status of patients with lymphoproliferative neoplasms before and after the first-line treatment	4
Challenges and considerations for antifungal prophylaxis in children with acute myeloid leukemia	4
The past, the present and the future of immune checkpoints inhibitors in multiple myeloma	4
Addressing unmet needs in rare bleeding disorders: selected poster extracts of recent research in hemophilia A and von Willebrand disease presented at the 14th Annual Congress of the European Associat	4
CircPTK2 promotes cell viability, cell cycle process, and glycolysis and inhibits cell apoptosis in acute myeloid leukemia by regulating miR-582-3p/ALG3 axis	4
Vasculopathy among children and adolescents with sickle cell disease: the crosstalk with annexin A1, vitamin D, and myocardial iron overload	4
Revolutionizing hypertension treatment: aprocitentan’s dual action against resistant hypertension	4
Pacritinib for the treatment of patients with myelofibrosis and thrombocytopenia	4
Procalcitonin as a diagnostic marker for infection in sickle cell disease	4
Advances in viral oncolytics for treatment of multiple myeloma – a focused review	4
Long non-coding RNA LOC644135 is a potential prognostic indicator in cytogenetically normal acute myeloid leukemia	4
The benefits of early intervention using lenalidomide for high-risk smoldering multiple myeloma: emerging data and its promising clinical impact	4
Effect of hydroxyurea on erythrocyte apoptosis in hemoglobinopathy patients	4
CD8+CD25+ Tregs as a predictor of glucocorticoid sensitivity in patients with immune thrombocytopenia	4
Five decades of successive establishment of hemophilia care in Thailand	4
A new decade awaits sticky platelet syndrome: where are we now, how do we manage and what are the complications?	4
Targeting CD123 in BPDCN: an emerging field	4
How clinicians and persons with hemophilia may approach shared decision-making	4
Effectiveness of myofascial therapy (MFT) along with traditional physiotherapy and intermittent prophylaxis on short-term improvement of joint health in hemophilic arthropathy: a randomized control tr	4
Immunotherapy for myelodysplastic syndrome and acute myeloid leukemia: where do we stand?	4
An evaluation of deferiprone as twice-a-day tablets or in combination therapy for the treatment of transfusional iron overload in thalassemia syndromes	4
Pregnancy and sickle cell disease: an overview of complications and suggested perinatal care	3
Correction	3
Current evidence on the use of direct oral anticoagulants in patients with myeloproliferative neoplasm: a systematic review	3
Positron emission tomography/magnetic resonance imaging (PET/MRI) vs. gastroscopy: Can it improve detection of extranodal marginal zone lymphomas of the stomach following H. pylori treatment?	3
The National Hemophilia Foundation State of the Science Research Summit initiative: executive summary	3
The role of intraarticular injections of hyaluronic acid in joint pain relief in hemophilic arthropathy	3
A deep dive into future therapies for microcytic anemias and clinical considerations	3
Letter to the Editor on “Hematopoietic cell transplants in resource-poor countries: challenges and opportunities”	3
Managing patients with myelofibrosis and thrombocytopenia	3
Copper deficiency, a rare but correctable cause of pancytopenia: a review of literature	3
Foreword: a special focus on bleeding disorders	3
Efficacy and safety of thrombopoietin receptor agonists in the treatment of thrombocytopenia after hematopoietic stem cell transplantation: a meta-analysis and systematic review	3
The potential of triplet combination therapies for patients with FLT3-ITD -mutated acute myeloid leukemia	3
Real-world effectiveness of voxelotor for treating sickle cell disease in the US: a large claims data analysis	3
Luspatercept as a therapy for myelodysplastic syndromes with ring sideroblasts	3
Soliciting international perspectives on an American national research agenda for inherited bleeding disorders	3
Evaluating ravulizumab for the treatment of children and adolescents with paroxysmal nocturnal hemoglobinuria	3
Clinical study on the prevention of deep vein thrombosis in patients with external fixation of lower limb fractures using an automatic ankle pump movement ceramic moxibustion rehabilitation device	3
Inhibitor eradication and treatment for acquired hemophilia A	3
Comparison of blinatumomab and CAR T-cell therapy in relapsed/refractory acute lymphoblastic leukemia: a systematic review and meta-analysis	3

Relationship between the ABO blood group and Rhesus factors with COVID-19 susceptibility	3
Long-term hypercoagulability, endotheliopathy and inflammation following acute SARS-CoV-2 infection	3
Is intensive chemotherapy and allogeneic stem cell transplantation mandatory for curing Philadelphia chromosome-positive acute lymphoblastic leukemia in young patients in the era of multitarget agents	3
G-CSF primary prophylaxis use and outcomes in patients receiving chemotherapy at intermediate risk for febrile neutropenia: a scoping review	3
New developments in the diagnosis and characterization of Waldenström’s macroglobulinemia	3
Update on iron supplementation in patients with cancer-related anemia	3
Transplant-associated thrombotic microangiopathy: elucidating prevention strategies and identifying high-risk patients	3
The promise of novel treatments for severe chronic neutropenia	3
Emerging small molecular inhibitors as targeted therapies for high-risk acute myeloid leukemias	3
An evaluation of fedratinib for adult patients with newly diagnosed and previously treated myelofibrosis	3
Reduction of ristocetin-induced platelet aggregation (RIPA) during storage despite plasma renewal: evidence for hemostatic importance of GPIbα shedding	3
Novel treatments for immune thrombocytopenia: targeting platelet autoantibodies	3
Novel approaches for preventing COVID-19 infection in immunocompromised patients with hematologic malignancies	3
Exploring the rationale for red cell transfusion in myelodysplastic syndrome patients: emerging data and future insights	3
An overview of novel therapies in advanced clinical testing for acute myeloid leukemia	3
Evaluating zanubrutinib for the treatment of adults with chronic lymphocytic leukemia or small lymphocytic lymphoma	3
Next generation anticoagulants: a spotlight on the potential role of activated factors XII and XI	3
Proximal complement inhibitors in paroxysmal nocturnal hemoglobinuria: an abundance of options in a rare disease	3
Immune thrombocytopenia: a review on the pathogenetic role of immune cells	2
Platelet indices in preeclampsia: comparative analysis with normotensive pregnant women	2
Keeping a balance in chronic lymphocytic leukemia (CLL) patients taking ibrutinib: ibrutinib-associated adverse events and their management based on drug interactions	2
DNA damage repair in megakaryopoiesis: molecular and clinical aspects	2
Dysregulated MAPK signaling pathway in acute myeloid leukemia with RUNX1 mutations	2
Enoxaparin adherence for venous thromboembolism prophylaxis in hospitalized patients with sickle cell disease	2
Addressing thrombosis concerns in immune thrombocytopenia: the role of fostamatinib in immune thrombocytopenia management	2
Looking to the future of gene therapy for hemophilia A and B	2
Is 50 mg/day the new standard dose of dasatinib in newly diagnosed patients with chronic myeloid leukemia in chronic phase?	2
Emicizumab: a novel drug in hemophilia A prophylaxis – a narrative review	2
Quality of life considerations in myelodysplastic syndrome: not only fatigue	2
Synchronizing the use of allogeneic hematopoietic cell transplantation in checkpoint blockade therapy for Hodgkin lymphoma	2
Identification and management of fetal anemia due to hemolytic disease	2
Safety of FLT3 inhibitors in patients with acute myeloid leukemia	2
An evaluation of von Willebrand factor (recombinant) therapy for adult patients living with severe type 3 von Willebrand disease	2
Subanesthetic ketamine: the way forward for pain management in sickle cell disease patients?	2
Quality of life considerations and management in patients with myelodysplastic syndrome	2
Improving symptom burden and quality of life in patients with myelofibrosis: current strategies and future directions	2
Emerging roles of microRNAs in acute lymphoblastic leukemia and their clinical prospects	2
Could targeted gene insertion of factor 9 be a potential durable treatment for Hemophilia B?	2
Overexpression of SCN5A overcomes ABC transporter-mediated multidrug resistance in acute myeloid leukemia through promoting apoptosis	2
Improving care for systemic light-chain amyloidosis patients: is a multidisciplinary approach best?	2
Anemia and iron overload as prognostic markers of outcomes in β-thalassemia	2
Gastrointestinal bleeding in von Willebrand patients: special diagnostic and management considerations	2
Global prophylaxis trends in hemophilia: a macroeconomic analysis and its association with world development indicators	2
The diagnosis, natural history, and management of von Willebrand disease in women in the age of guidelines	2
Building the foundation for a community-generated national research blueprint for inherited bleeding disorders: research priorities to transform the care of people with hemophilia	2
The efficiency of autologous stem cell transplantation as the first-line treatment for nodal peripheral T-cell lymphoma: results of a systematic review and meta-analysis	2
Redefining efficacy and safety endpoints for chronic lymphocytic leukemia in the era of targeted therapy	2
Olutasidenib: a novel mutant IDH1 inhibitor for the treatment of relapsed or refractory acute myeloid leukemia	2
Management of patients with antiphospholipid antibodies: what to do in laboratory scenarios that do not fit the guidelines	2
An evaluation of isatuximab, pomalidomide and dexamethasone for adult patients with relapsed and refractory multiple myeloma	2
Ankle arthrodesis and total ankle replacement in patients with congenital bleeding disorders suffering from severe ankle arthropathy	2
Oral ferroportin inhibitor vamifeport for improving iron homeostasis and erythropoiesis in β-thalassemia: current evidence and future clinical development	2
Reduced CXCR4 expression in associated with extramedullary and predicts poor survival in newly diagnosed multiple myeloma	2
Modulation of the endocannabinoid system in chronic conditions: a potential therapeutic intervention yet to be explored in sickle cell disease	2
Polycythemia vera: aspects of its current diagnosis and initial treatment	2
Investigation of demographic features, performance, comorbidity status and mortality causes among multiple myeloma patients: real-life data	1
Frontline combination of dasatinib and low-intensity chemotherapy in adults with de novo Philadelphia chromosome-positive acute lymphoblastic leukemia	1
Risk of vaso-occlusive episodes in patients with sickle cell disease exposed to systemic corticosteroids: a comprehensive review	1
A narrative review of consolidation strategies for young and fit patients with newly-diagnosed primary central nervous system lymphoma	1
Nodular lymphocyte-predominant Hodgkin lymphoma: current management strategies and evolving approaches to individualize treatment	1
COVID-19 associated thrombotic thrombocytopenic purpura: a case report and review of the literature	1
Construction of a DLBCL Prognostic Signature Based on Tumor Microenvironment	1
Clinical challenges and promising therapies for chemotherapy-induced thrombocytopenia	1
Utilizing the prognostic impact of minimal residual disease in treatment decisions for pediatric acute lymphoblastic leukemia	1
Clinical characteristics of HFE C282Y/H63D compound heterozygotes identified in a specialty practice: key differences from HFE C282Y homoz	1
Identification of miR-451 target genes as prognostic markers in diffuse large B-cell lymphoma	1
Evaluation of the effect of voxelotor and darbepoetin alfa on hemoglobin levels in patients with sickle cell disease	1
Targeting Ikaros and Aiolos: reviewing novel protein degraders for the treatment of multiple myeloma, with a focus on iberdomide and mezigdomide	1
Exercise and anemia in cancer patients: could it make the difference?	1
Efficacy of azacitidine in preventing relapse after hematopoietic stem cell transplantation for advanced myeloid malignancies: a systematic review and meta-analysis	1
A systematic review of the predicted outcomes related to hematopoietic stem cell transplantation: focus on applied machine learning methods’ performance	1
Managing hypogammaglobulinemia in patients treated with CAR-T-cell therapy: key points for clinicians	1
Strategies to improve pharmacogenomic-guided treatment options for patients with β-hemoglobinopathies	1
lncRNA GAS 5 rs145204276 as a risk factor for primary immune thrombocytopenia in the Chinese Han population	1
Real-world study of rurioctocog alfa pegol and emicizumab in US clinical practice among patients with hemophilia A	1
Total elbow arthroplasty in hemophilia: a high-risk surgical procedure	1
Clinical status of induction therapy incorporating a hypomethylating agent for newly diagnosed adult acute myeloid leukemia compared to the standard 7+3 regimen	1
Anemia and its predictors among patients on hemodialysis, at Felege Hiote Referral Hospital, Northwest Ethiopia, 2022: a retrospective cohort study	1
Role of daratumumab in the frontline management of multiple myeloma: a narrative review	1
Best practices and recommendations for drug regimens and plasma exchange for immune thrombotic thrombocytopenic purpura	1
Graft-versus-host disease after an outpatient peripheral blood hematopoietic cell transplant using reduced-intensity conditioning: a single-center LATAM experience	1
Applying World Health Organization 2020 guidelines on physical activity and sedentary behavior to people with hemophilia	1
Assessing eligibility for treatment in acute myeloid leukemia in 2023	1
Immunogenicity, safety, and efficacy of rurioctocog alfa pegol in previously untreated patients with severe hemophilia A: interim results from a phase 3, prospective, multicenter, open-label study	1
Efficacy and safety of caplacizumab in the treatment of thrombotic thrombocytopenic purpura: a systematic review and meta-analysis	1
Management of acute chest syndrome in patients with sickle cell disease: a systematic review of randomized clinical trials	1
Complement-directed therapy for cold agglutinin disease: sutimlimab	1
Hemophilic arthropathy: a teaching approach devoted to hemophilia treaters in under-development countries	1
Chemotherapy-free approaches to newly-diagnosed acute promyelocytic leukaemia: is oral-arsenic trioxide/all-trans retinoic acid/ascorbic acid the answer?	1
Clinical trials, challenges, and changes in TCR-based therapeutics for hematologic malignancies	1
Idecabtagene vicleucel versus ciltacabtagene autoleucel: a Sophie’s choice for patients with relapsed refractory multiple myeloma	1
Molecular therapeutics of hemophilia A and B	1
Current status of drug repositioning in hematology	1
The influence of lymphoid enhancer binding factor-1 expression on the outcome of adult acute promyelocytic leukemia patients	1
In the era of primary prophylaxis in hemophilia, what types of orthopedic surgical interventions have been published in the 2020–2023 period and in which countries?	1